医学AI 周报 · 行业新闻

The FDA has been approving AI-based devices for years but didn’t initially distinguish them as a unique category. A few years back, we at The Medical Futurist Institute took it upon ourselves to sift

As artificial intelligence (AI) has been highly advancing in the last decade, machine learning (ML)-enabled medical devices are increasingly used in healthcare. In this study, we collected publicly av

Despite the increasing number of AI-enabled medical devices the FDA has yet to establish a unique regulatory pathway for these devices. Most approvals follow a 510(k) pathway according to their risk l

Dec 05, 2024 - 01:45 PM FDA Update 900x400 The Food and Drug Administration yesterday released recommendations for streamlining the approval process for medical devices that use artificial intellige

Per section 201(h) of the Food, Drug and Cosmetic Act, certain AI applications are considered medical devices if they are “intended for use in the diagnosis of disease or other conditions, or in the c

# Artificial intelligence (AI) and the healthcare industry Artificial intelligence (AI) is transforming the healthcare industry, revolutionizing the way care is delivered, research is conducted, and

How Has AI Impacted the Health Industry? AI for healthcare offers the ability to process and analyze vast amounts of medical data far beyond human capacity. The benefits of AI in healthcare include f

Global market for Artificial Intelligence (AI) in Healthcare was valued at US$ 25.64 Billion in 2023 Annual market size is expected to reach US$ 519.73 Billion by 2031 Total addressable market (TAM)

At Google DeepMind, our journey in medical AI has evolved from mastering examination-style tests of medical knowledge with MedPaLM, to matching physician performance in text-based simulated medical co

In this episode, discover how Google's DeepMind AI is transforming medical care. We explore three key questions: How does DeepMind detect illnesses early? How will this technology improve healthcare f

Today in Nature Medicine, we’ve published our joint paper with Google Research, which proposes CoDoC (Complementarity-driven Deferral-to-Clinical Workflow), an AI system that learns when to rely on pr

AlphaFold, an AI model from Google DeepMind, is revolutionizing our understanding of proteins, the building blocks of life. By rapidly predicting their complex 3D shapes, AlphaFold is supporting scien

DeepMind Technologies Limited, trading as Google DeepMind or simply DeepMind, is a British-American artificial intelligence (AI) research laboratory which serves as a subsidiary of Alphabet Inc. Found

SOAPNoteAI Logo SOAPNoteAI.com SOAPNoteAI Logo SOAPNoteAI.com ## Product ## AI Scribe by Practice ## SOAP Note Guides ## SOAP Note Examples ## New for 2026 ## 2026 Resources ## Documentation

significant aspect of OpenAI’s healthcare strategy involves partnering with leading healthcare institutions to explore AI’s potential in clinical and operational settings. Hospitals, academic medical

On Jan. 8, the company announced “OpenAI for Healthcare”, a suite of HIPAA-compliant AI tools with clinical and administrative use cases. The announcement featured two major products: ChatGPT for Hea

OpenAI for healthcare # Enterprise AI built for safer, more efficient care Scale high-quality care with an AI platform that supports HIPAA compliance and provides clinical-grade intelligence across

January 8, 2026 # Introducing OpenAI for Healthcare Secure AI products to help healthcare organizations scale high-quality care, reduce admin work for teams, and power custom clinical solutions—whil

In fact, a recent study analyzed the success of AI-discovered drugs in clinical trials, highlighting their growing impact on pharmaceutical research. The study found that AI-driven biotech companies h

Latshaw says the application of AI across the clinical trial process, from design to recruitment and analysis, can speed up the process by 50% compared with traditional methods. The FDA, which holds

Artificial Intelligence (AI) has revolutionized the field of drug discovery, and a growing number of AI-discovered drugs are advancing into clinical trials, with an 80–90% success rate in phase 1 tria

Skip to main content News & Views Published: Machine learning # AI-enabled drug discovery reaches clinical milestone Marinka Zitnik ORCID: orcid.org/0000-0001-8530-72281,2,3,4 Nature Medici

AI in pharmacology is transformative due to its ability to process and interpret scientific information on an unprecedented scale. According to Wang et al., AI systems in drug discovery can read, proc

# 2025 year-end digital health funding overview: A tale of two markets In a turbulent year for healthcare and the broader market, digital health started to feel less like a tremor of innovation and m

The top ten digital health startups represent about $7.0B in funding, which shows that capital is concentrated around a small group of scaled platforms. Mental health is the deepest digital health fu

## TL;DR With global digital health startup funding reaching a monumental $29.7 billion in 2025, Galen Growth’s latest intelligence platform provides a decision-grade roadmap for navigating the secto

The digital health landscape enters 2026 at an inflection point. According toRock Health's 2025 year-end report, U.S. digital health companies raised $14.2 billion in venture funding—a 35% increase ov

Awards + DEI Awards + Innovation Awards Resources + Webinars + Fierce Events + Industry Events + Podcasts + Survey + Whitepapers Events Subscribe Fierce Pharma Fierce Biotech Fi